Try it
Anaesthesia · Malignant hyperthermia
Sample itemSoon after volatile anesthesia begins, end-tidal CO2 rises rapidly despite increased ventilation, with generalized rigidity, tachycardia, and increasing temperature. What is the specific treatment?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Dantrolene and discontinuation of triggering agents
Malignant hyperthermia is a hypermetabolic crisis triggered by volatile anesthetics or succinylcholine in susceptible individuals. Immediate treatment includes stopping triggers, administering dantrolene, active supportive management, and treating complications such as hyperkalemia.
Option by option
A. Dantrolene and discontinuation of triggering agents (correct)
Correct. Dantrolene directly reduces abnormal skeletal-muscle calcium release.
B. Neostigmine and atropine
Neostigmine and atropine are used for reversal of some nondepolarizing blocks.
C. Naloxone infusion
Naloxone reverses opioid effects, not this hypermetabolic crisis.
D. Intravenous insulin only
Insulin may help treat hyperkalemia but is not definitive treatment for malignant hyperthermia.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Anaesthesia questions
- Malignant hyperthermiaDuring general anaesthesia with sevoflurane and succinylcholine, a patient develops unex…
- Malignant hyperthermiaA 20-year-old man is anaesthetised with sevoflurane and suxamethonium. Soon afterwards h…
- Malignant hyperthermiaSpecific therapy for MH is what?
- Malignant hyperthermiaWhich sign should raise concern for malignant hyperthermia during anesthesia?